Beranda › Kanker Kandung Kemih › Distrik Columbia › Washington
Uji klinis Kanker Kandung Kemih di Washington, DC
26 studi untuk Kanker Kandung Kemih mencari peserta di lokasi sekitar Washington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
The Vanguard Study: Testing a New Way to Screen for Cancer
Menerima pesertaSukarelawan sehat diterima
- Walter Reed National Military Medical Center, Bethesda · 7 mi jauhnya
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Menerima pesertaFase 3
- Sibley Memorial Hospital, Washington D.C.
Evaluation for NCI Surgery Branch Clinical Research Protocols
Menerima pesertaStudi observasional
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
Menerima pesertaStudi observasional
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi jauhnya
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Menerima pesertaFase 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Menerima pesertaFase 1/2
- Sibley Memorial Hospital Pharmacy Department, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Menerima pesertaFase 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Menerima pesertaFase 3
- Sibley Memorial Hospital ( Site 0849), Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Menerima pesertaFase 3
- MedStar Washington Hospital Center, Washington D.C.
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- National Institutes of Health, Bethesda · 7 mi jauhnya
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Menerima pesertaStudi observasional
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Menerima pesertaFase 1/2
- The George Washington Medical Faculty Associates, Washington D.C.
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Menerima pesertaFase 2/3
- Sibley Memorial Hospital, Washington D.C.
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Menerima pesertaFase 2
- Medstar Washington Hospital Center, Washington D.C.
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Menerima pesertaFase 2
- Johns Hopkins University: Sibley Memorial Hospital, Washington D.C.
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Menerima pesertaFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Cancer Support Community Research & Training Institute, Washington D.C.
Renal Retention in High Grade Upper Tract Urothelial Cancer
Menerima pesertaFase 2
- Johns Hopkins University: Sibley Memorial Hospital, Washington D.C.
Blue Light Cystoscopy With Cysview® Registry
Menerima pesertaStudi observasional
- Sibley Memorial Hospital, Washington D.C.
Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
Menerima peserta
- Sibley Memorial Hospital, Washington D.C.
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
Menerima pesertaFase 3
- Sibley Memorial Hospital, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi jauhnya
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi jauhnya
Gender Related Coping and Survivorship for Genitourinary Cancers
Menerima pesertaStudi observasional
- Sibley Memorial Hospital, Washington D.C.
Uji klinis Kanker Kandung Kemih di kota lain
- New York City, NY35 studi
- Nashville, TN31 studi
- Houston, TX31 studi
- Dallas, TX27 studi
- Boston, MA26 studi
- Baltimore, MD24 studi
- Los Angeles, CA24 studi
- St. Louis, MO22 studi
- Seattle, WA21 studi
- Philadelphia, PA21 studi
- Chicago, IL21 studi
- Edison, NJ21 studi
Studi lain di Washington
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil55 studi
- Kanker Payudara46 studi
- Kanker Metastatik43 studi
- Kanker Paru41 studi
- Kanker Prostat38 studi
- Obesitas33 studi
- Kanker Kolorektal29 studi
- Penyakit Kardiovaskular28 studi
- Leukemia Mieloid Akut24 studi
- Kanker Ovarium23 studi
- Limfoma23 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.